LDL cholesterol is an important contributor to the risk of coronary heart disease, and its measurement is central to evaluating the effects of lipid-modifying therapies. Several ‘LDL-cholesterol’ assays exist but their methodologies differ, leading to between-assay heterogeneity in values of ‘LDL cholesterol’. We advocate the need for awareness of the potential implications.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
HPS3/TIMI55-REVEAL Collaborative Group. Effects of anacetrapib in patients with atherosclerotic vascular disease. N. Engl. J. Med. 377, 1217–1227 (2017).
Boren, J. & Williams, K. J. The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: a triumph of simplicity. Curr. Opin. Lipidol. 27, 473–483 (2016).
Kettunen, J. et al. Lipoprotein signatures of cholesteryl ester transfer protein and HMG-CoA reductase inhibition. Preprint at bioRxiv https://doi.org/10.1101/295394 (2018).
Sliz, E. et al. Metabolomic consequences of genetic inhibition of PCSK9 compared with statin treatment. Circulation 138, 2499–2512 (2018).
Acknowledgements
M.V.H. is supported by a British Heart Foundation Intermediate Clinical Research Fellowship (FS/18/23/33512). M.A.-K. is supported by a Senior Research Fellowship from the National Health and Medical Research Council (NHMRC) of Australia (APP1158958) and works in a Unit that is supported by the University of Bristol and UK Medical Research Council (MC_UU_12013/1).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Holmes, M.V., Ala-Korpela, M. What is ‘LDL cholesterol’?. Nat Rev Cardiol 16, 197–198 (2019). https://doi.org/10.1038/s41569-019-0157-6
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41569-019-0157-6